Suit Alleges More Health Problems From Merck's Fosamax Drug
January 28, 2008 12:32

A Connecticut woman has sued Merck & Co., claiming that its osteoporosis drug Fosamax caused multiple stress fractures and suppressed bone regeneration in her legs. JoAnn Moranski of Fairfield alleges in a complaint filed in New Jersey state court that she took the drug from 1996-2006. http://online.wsj.com/article/SB120154745351022967.html?mod=googlenews_wsj

Denosumab Osteoporosis Study Met Primary And All Secondary Bone Mineral Density Endpoints In A Head-to Head Comparison
January 29, 2008 16:56

Medical News Today, Mon, 28 Jan 2008 1:17 AM PST http://www.medicalnewstoday.com/articles/95280.php
Amgen (NASDAQ:AMGN) announced findings from a head-to-head, double-blind study comparing the effects of twice-yearly subcutaneous injections of denosumab versus weekly oral doses of alendronate (FOSAMAX(R)) on bone mineral density (BMD) in postmenopausal women with low bone mineral density. The study met primary and all secondary endpoints.

Trouble Brews Over Merck Product - FOSAMAX LAWSUITS MOVE FORWARD
January 31, 2008 09:44

Merck & Co.'s pending $4.85 billion Vioxx settlement is expected to bring more than three years of litigation to an end. But looming challenges to some top-selling products, including osteoporosis blockbuster Fosamax, threaten to keep the company under a cloud. see: http://online.wsj.com/article/SB120165519331327133.html